Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.13 - $12.03 $196 - $18,225
-1,515 Reduced 3.79%
38,503 $5,000
Q3 2022

Nov 14, 2022

BUY
$0.53 - $13.3 $22 - $571
43 Added 0.11%
40,018 $19,000
Q2 2022

Aug 12, 2022

SELL
$0.56 - $1.22 $2,635 - $5,741
-4,706 Reduced 10.53%
39,975 $28,000
Q1 2022

May 16, 2022

SELL
$1.11 - $2.25 $21,192 - $42,957
-19,092 Reduced 29.94%
44,681 $52,000
Q4 2021

Feb 14, 2022

BUY
$1.35 - $4.89 $35,060 - $126,998
25,971 Added 68.7%
63,773 $134,000
Q3 2021

Nov 15, 2021

BUY
$0.67 - $3.41 $3,573 - $18,188
5,334 Added 16.43%
37,802 $57,000
Q2 2021

Aug 16, 2021

BUY
$2.11 - $4.93 $5,076 - $11,861
2,406 Added 8.0%
32,468 $116,000
Q1 2021

May 13, 2021

SELL
$3.91 - $7.31 $313,366 - $585,859
-80,145 Reduced 72.72%
30,062 $143,000
Q4 2020

Feb 09, 2021

SELL
$3.27 - $9.48 $968,554 - $2.81 Million
-296,194 Reduced 72.88%
110,207 $586,000
Q3 2020

Nov 05, 2020

SELL
$7.71 - $10.79 $203,613 - $284,953
-26,409 Reduced 6.1%
406,401 $3.67 Million
Q2 2020

Aug 13, 2020

BUY
$9.0 - $13.12 $3.9 Million - $5.68 Million
432,810 New
432,810 $3.9 Million

Others Institutions Holding BIOR

About BIORA THERAPEUTICS, INC.


  • Ticker BIOR
  • Exchange NASDAQ
  • Shares Outstandng 186,623,605
  • Market Cap $41.1M
  • Description
  • Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...
More about BIOR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.